Feng Shi

3PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 09, 2026
AL2846, a Novel Multi-Kinase Inhibitor, for Previously Treated Radioiodine-Refractory Differentiated Thyroid Cancer: Exploratory Clinical Results From the Phase Ib Study.

Feng Shi, Wenwen Chai, Hui Yang

|Aug 18, 2023
Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial.

Yihebali Chi, Xiangqian Zheng, Yuan Zhang

|May 15, 2023
Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.

Yansong Lin, Shukui Qin, Hui Yang

Pageof 1

Frequent Collaborators

2 joint publications

Zhendong Li

2 joint publications

Hui Yang

2 joint publications

Yuan Zhang

2 joint publications

Yali Cui